Irene Polycarpou

Dr. Irene Polycarpou

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MAMaria Andreou
Maria Andreou
MKMaria Kyprianidou
Maria Kyprianidou
CCChristos Cortas
Christos Cortas
IPIrene Polycarpou
Irene Polycarpou
DPDemetris Papamichael
Demetris Papamichael
KGKonstantinos Giannakou
Konstantinos Giannakou
Objective: To analyze the factors associated with overall survival (OS) and progression-free survival (PFS) in patients with ovarian cancer in Cyprus. Methods: We retrospectively analyzed data from patients with histologically confirmed epithelial ovarian cancer (EOC) and primary peritoneal cancer (PPC). Results: A total of 106 women diagnosed with ovarian cancer were included, with a median age at diagnosis of 58 years. The Kaplan–Meier survival analysis showed a median OS of 41 months (95% C.I = 36.9, 45.1), and the FIGO stage (p < 0.001), type of surgery (p < 0.001) and performance status (p < 0.001) were identified as statistically significant prognostic factors for OS. PFS analysis revealed the FIGO stage (p = 0.006) and the performance status (p < 0.001) as significant prognostic factors. Additionally, a Cox regression analysis for median OS was performed for patients with high-grade serous carcinoma, identifying the performance status, FIGO stage, and type of surgery as prognostic factors in univariate analysis. However, in the subsequent multivariate analysis, the performance status and the FIGO stage were confirmed to be the only statistically significant prognostic factors for OS (p < 0.05). Conclusions: This study confirms that the FIGO stage, performance status, and surgery type were considered as prognostic factors for OS in ovarian cancer.

5 July 2021 in Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences
Verified
Journal Article
Open access
IPIrene Polycarpou
Irene Polycarpou
GSGeorgios Soultanidis
Georgios Soultanidis
CTCharalampos Tsoumpas
Charalampos Tsoumpas
Subject motion in positron emission tomography (PET) is a key factor that degrades image resolution and quality, limiting its potential capabilities. Correcting for it is complicated due to the lack of sufficient measured PET data from each position. This poses a significant barrier in calculating the amount of motion occurring during a scan. Motion correction can be implemented at different stages of data processing either during or after image reconstruction, and once applied accurately can substantially improve image quality and information accuracy. With the development of integrated PET-MRI (magnetic resonance imaging) scanners, internal organ motion can be measured concurrently with both PET and MRI. In this review paper, we explore the synergistic use of PET and MRI data to correct for any motion that affects the PET images. Different types of motion that can occur during PET-MRI acquisitions are presented and the associated motion detection, estimation and correction methods are reviewed. Finally, some highlights from recent literature in selected human and animal imaging applications are presented and the importance of motion correction for accurate kinetic modelling in dynamic PET-MRI is emphasized. This article is part of the theme issue ‘Synergistic tomographic image reconstruction: part 2’.

6 January 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
JAJawaher Almaimani
Jawaher Almaimani
CTCharalampos Tsoumpas
Charalampos Tsoumpas
RFRichard Feltbower
Richard Feltbower
IPIrene Polycarpou
Irene Polycarpou
The management of non-Hodgkin lymphoma (NHL) patients requires the identification of bone marrow involvement (BMI) using a bone marrow biopsy (BMB), as recommended by international guidelines. Multiple studies have shown that [18F]FDG positron emission tomography, combined with computed tomography (PET/CT), may provide important information and may detect BMI, but there is still an ongoing debate as to whether it is sensitive enough for NHL patients in order to replace or be used as a complimentary method to BMB. The objective of this article is to systematically review published studies on the performance of [18F]FDG PET/CT in detecting BMI compared to the BMB for NHL patients. A population, intervention, comparison, and outcome (PICO) search in PubMed and Scopus databases (until 1 November 2021) was performed. A total of 41 studies, comprising 6147 NHL patients, were found to be eligible and were included in the analysis conducted in this systematic review. The sensitivity and specificity for identifying BMI in NHL patients were 73% and 90% for [18F]FDG PET/CT and 56% and 100% for BMB. For aggressive NHL, the sensitivity and specificity to assess the BMI for the [18F]FDG PET/CT was 77% and 94%, while for the BMB it was 58% and 100%. However, sensitivity and specificity to assess the BMI for indolent NHL for the [18F]FDG PET/CT was 59% and 85%, while for the BMB it was superior, and equal to 94% and 100%. With regard to NHL, a [18F]FDG PET/CT scan can only replace BMB if it is found to be positive and if patients can be categorized as having advanced staged NHL with high certainty. [18F]FDG PET/CT might recover tumors missed by BMB, and is recommended for use as a complimentary method, even in indolent histologic subtypes of NHL.

30 October 2017 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
IPIrene Polycarpou
Irene Polycarpou
GSGeorgios Soultanidis
Georgios Soultanidis
CTCharalampos Tsoumpas
Charalampos Tsoumpas
The investigation of the performance of different Positron Emission Tomography (PET) reconstruction and motion compensation methods requires accurate and realistic representation of the anatomy and motion trajectories as observed in real subjects during acquisitions. The generation of wellcontrolled clinical datasets is difficult due to the many different clinical protocols, scanner specifications, patient sizes and physiological variations. Alternatively, computational phantoms can be used to generate large datasets for different disease states, providing a ground truth. Several studies use registration of dynamic images to derive voxel deformations to create moving computational phantoms. These phantoms together with simulation software generate raw data. This paper proposes a method for the synthesis of dynamic PET data using a fast analytic method. This is achieved by incorporating realistic models of respiratory motion into a numerical phantom to generate datasets with continuous and variable motion with Magnetic Resonance Imaging (MRI)-derived motion modeling and high resolution MRI images. In this paper, datasets for two different clinical traces are presented, 18F-FDG and 68Ga-PSMA. This approach incorporates realistic models of respiratory motion to generate temporally and spatially correlated MRI and PET datasets, as those expected to be obtained from simultaneous PET-MRI acquisitions.

18 September 2015 in BioMedical Engineering OnLine
Verified
Journal Article
Open access
PDF file
DBDaniel R. Balfour
Daniel R. Balfour
PMPaul K. Marsden
Paul K. Marsden
IPIrene Polycarpou
Irene Polycarpou
CKChristoph Kolbitsch
Christoph Kolbitsch
AKAndrew P. King
Andrew P. King
Respiratory motion in positron emission tomography (PET) is an unavoidable source of error in the measurement of tracer uptake, lesion position and lesion size. The introduction of PET-MR dual modality scanners opens a new avenue for addressing this issue. Motion models offer a way to estimate motion using a reduced number of parameters. This can be beneficial for estimating motion from PET, which can otherwise be difficult due to the high level of noise of the data. We propose a novel technique that makes use of a respiratory motion model, formed from initial MR scan data. The motion model is used to constrain PET-PET registrations between a reference PET gate and the gates to be corrected. For evaluation, PET with added FDG-avid lesions was simulated from real, segmented, ultrashort echo time MR data obtained from four volunteers. Respiratory motion was included in the simulations using motion fields derived from real dynamic 3D MR volumes obtained from the same volunteers. Performance was compared to an MR-derived motion model driven method (which requires constant use of the MR scanner) and to unconstrained PET-PET registration of the PET gates. Without motion correction, a median drop in uncorrected lesion $${\mathrm {SUV}}_{\mathrm {peak}}$$ SUV peak intensity to $$78.4 \pm 18.6 \,\,\%$$ 78.4 ± 18.6 % and an increase in median head-foot lesion width, specified by a minimum bounding box, to $$179 \pm 63.7\,\, \%$$ 179 ± 63.7 % was observed relative to the corresponding measures in motion-free simulations. The proposed method corrected these values to $$86.9 \pm 13.6\,\, \%$$ 86.9 ± 13.6 % ( $$p<0.001$$ p < 0.001 ) and $$100 \pm 29.12\,\, \%$$ 100 ± 29.12 % ( $$p<0.001$$ p < 0.001 ) respectively, with notably improved performance close to the diaphragm and in the liver. Median lesion displacement across all lesions was observed to be $$6.6 \pm 5.4\,\mathrm {mm}$$ 6.6 ± 5.4 mm without motion correction, which was reduced to $$3.5 \pm 1.8\,\mathrm {mm}$$ 3.5 ± 1.8 mm ( $$p<0.001$$ p < 0.001 ) with motion correction. This paper presents a novel technique for respiratory motion correction of PET data in PET-MR imaging. After an initial 30 second MR scan, the proposed technique does not require use of the MR scanner for motion correction purposes, making it suitable for MR-intensive studies or sequential PET-MR. The accuracy of the proposed technique was similar to both comparative methods, but robustness was improved compared to the PET-PET technique, particularly in regions with higher noise such as the liver.